Hepatitis C News

Kidney transplant recipients with hepatitis B and hepatitis C in whom viral replication was controlled had similar overall and graft survival rates as patients without viral hepatitis, according to data published in Journal of Hepatology.

An analysis of patients with HIV who were being treated for hepatitis C virus infection found that 7% failed direct-acting antiviral therapy, and that mental illness and ongoing illicit drug use often predicted failure, researchers reported.

SEATTLE — A small pilot study of hepatitis C treatment in pregnant women found that their response to ledipasvir-sofosbuvir therapy is similar to the viral response observed in nonpregnant individuals and identified no safety concerns associated with treatment, according to findings presented at CROI.

Long-term surveillance among men who have sex with men with HIV after clearance of hepatitis C may be warranted as reinfection rates remain high and continue to occur more than 11 years after clearance regardless of treatment, according to a study presented at CROI.

The rates of hepatitis C incidence among men who have sex with men with HIV has significantly decreased in London since the epidemic peak in 2015, coinciding with wider access to direct-acting antiviral therapy, according to data presented at CROI.

SEATTLE — A recent analysis found that IV drug use and hepatitis C virus infection were the best predictors of incident syphilis among women with HIV.

All patients who completed direct-acting antiviral therapy after orthotopic heart transplantation with hepatitis C-positive donor hearts achieved sustained virologic, according to results from a recent study.

AbbVie announced an agreement with the pan-Canadian Pharmaceutical Alliance in which Ontario will be first province to reimburse the hepatitis C direct-acting antiviral Maviret on its public formulary as of February 28, 2019, according to a press release.

Researchers determined a target limit of detection for hepatitis C point-of-care tests that would identify 97% of viremic infections among all populations including low- and middle-income countries, according to a recently published study.

Study findings showed a higher prevalence of HIV among women who inject drugs compared with men, and researchers recommended developing gender-sensitive harm reduction services.